À retenir
An armband prototype combining ECG and pulse (PPG) sensors estimated systolic blood pressure with a mean error of 1.63 ± 4.44 mmHg on unseen data and heart rate with a mean absolute error of 0.21 beats per min. Data came from only ten volunteers, so this is a proof of concept and not evidence that it is accurate enough for real-world use.
Study design
Article de recherche
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Continuous blood pressure monitoring without a cuff would be valuable for heart health, stress and fitness tracking, but current approaches are hard to wear, lack robust models and are rarely tested on new data. The authors built a single-arm ECG and PPG device and tested whether it could estimate systolic blood pressure (SBP) and heart rate.
Population et méthode
Engineering proof-of-concept study. ECG and PPG sensors were integrated into one upper-arm band, with a single-lead arm ECG instead of chest or two-wrist electrodes. A machine learning framework identified heartbeats and heart rate from the motion-sensitive weak arm ECG, and ECG-PPG heartbeat pairs gave pulse transit time (PTT). A model using PTT and heart rate (PTT&HR-SBP) was compared with PTT-only models, and fitted models were evaluated on unseen data. A customized prototype and a dataset from ten volunteers were used. The abstract does not describe the volunteers or the reference blood pressure method.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1The prototype acquired PPG and a weak ECG from the left upper arm; the ECG amplitude was only around 10% of chest ECG.
- 2Heart rate estimation had a mean absolute error of 0.21 beats per min and a root mean square error of 1.20 beats per min.
- 3Models combining PTT and heart rate significantly outperformed PTT-only models for SBP.
- 4On unseen data, SBP error was 1.63 ± 4.44 mmHg (mean error ± standard deviation), with a mean absolute error of 3.68 mmHg and root mean square error of 4.71 mmHg.
Limites et incertitude
- 1Only ten volunteers were studied, and the abstract does not say whether they included people with high blood pressure.
- 2The device is a semi-customized prototype tested in a proof-of-concept setting, not a consumer product.
- 3The abstract reports only systolic pressure, and does not report diastolic pressure or performance over long periods, activity or changes in medication.
- 4This reading is based on the abstract only.
Mise en perspective
The result shows that a cuff-less arm-worn design can be reasonably close to reference readings in a small test, which is encouraging for future wearables. It does not mean you can replace a validated blood pressure cuff with a device like this, and any hypertension decision belongs with your clinician.
Vos données
If you use a cuff-less wearable, treat its blood pressure number as a rough trend and check it against a validated upper-arm cuff, measured seated and rested at the same time of day. Trends over weeks matter more than a single reading.
Comprendre ce type de preuve
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Long-term continuous systolic blood pressure (SBP) and heart rate (HR) monitors are of tremendous value to medical (cardiovascular, circulatory and cerebrovascular management), wellness (emotional and stress tracking) and fitness (performance monitoring) applications, but face several major impediments, such as poor wearability, lack of widely accepted robust SBP models and insufficient proofing of the generalization ability of calibrated models.
Methods
This paper proposes a wearable cuff-less electrocardiography (ECG) and photoplethysmogram (PPG)-based SBP and HR monitoring system and many efforts are made focusing on above challenges. Firstly, both ECG/PPG sensors are integrated into a single-arm band to provide a super wearability. A highly convenient but challenging single-lead configuration is proposed for weak single-arm-ECG acquisition, instead of placing the electrodes on the chest, or two wrists. Secondly, to identify heartbeats and estimate HR from the motion artifacts-sensitive weak arm-ECG, a machine learning-enabled framework is applied. Then ECG-PPG heartbeat pairs are determined for pulse transit time (PTT) measurement. Thirdly, a PTT&HR-SBP model is applied for SBP estimation, which is also compared with many PTT-SBP models to demonstrate the necessity to introduce HR information in model establishment. Fourthly, the fitted SBP models are further evaluated on the unseen data to illustrate the generalization ability. A customized hardware prototype was established and a dataset collected from ten volunteers was acquired to evaluate the proof-of-concept system.
Results
The semi-customized prototype successfully acquired from the left upper arm the PPG signal, and the weak ECG signal, the amplitude of which is only around 10% of that of the chest-ECG. The HR estimation has a mean absolute error (MAE) and a root mean square error (RMSE) of only 0.21 and 1.20 beats per min, respectively. Through the comparative analysis, the PTT&HR-SBP models significantly outperform the PTT-SBP models. The testing performance is 1.63 ± 4.44, 3.68, 4.71 mmHg in terms of mean error ± standard deviation, MAE and RMSE, respectively, indicating a good generalization ability on the unseen fresh data.
Conclusions
The proposed proof-of-concept system is highly wearable, and its robustness is thoroughly evaluated on different modeling strategies and also the unseen data, which are expected to contribute to long-term pervasive hypertension, heart health and fitness management.
Sources et attribution
Highly wearable cuff-less blood pressure and heart rate monitoring with single-arm electrocardiogram and photoplethysmogram signals.
Zhang Q, Zhou D, Zeng X.
Biomedical engineering online · 2017-02-06
DOI: 10.1186/s12938-017-0317-z ↗PubMed · 28166774 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

